Efficacy and Safety of Pegylated Liposomal Doxorubicin-Based Chemotherapy of AIDS-Related Kaposi's Sarcoma: A Meta-Analysis

Am J Ther. 2018 Nov/Dec;25(6):e719-e721. doi: 10.1097/MJT.0000000000000736.

Authors

Rong Liu¹, Jie Zhou¹, Shuhong Yang², Zhen Zhang¹

Affiliations

¹ School of Medicine and Nursing, Chengdu University, Chengdu, China.
² School of Life Science and Engineering, LanZhou University of Technology, Lanzhou, China.

PMID: 29509553
DOI: 10.1097/MJT.0000000000000736

No abstract available

Publication types

Letter
Meta-Analysis

MeSH terms

AIDS-Related Opportunistic Infections / drug therapy*
Antibiotics, Antineoplastic / therapeutic use*
Doxorubicin / analogs & derivatives*
Doxorubicin / therapeutic use
Humans
Incidence
Leukopenia / chemically induced
Leukopenia / epidemiology*
Polyethylene Glycols / therapeutic use
Sarcoma, Kaposi / drug therapy*
Treatment Outcome

Substances

Antibiotics, Antineoplastic
liposomal doxorubicin
Polyethylene Glycols
Doxorubicin

Supplementary concepts

AIDS-related Kaposi sarcoma